Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV dexamethasone versus methylprednisolone for pediatric asthma attacks
IRCT20251201068170N1Phase 2Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Feb 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in asthma comparing Standard treatment + dexamethasone with Standard treatment + methylprednisolone succinate (2 arms). Primary endpoints: Asthma attack severity by Pediatric Respiratory Assessment Measure, Blood oxygen saturation and 7 more. Started Feb 2026; status: completed.
02
Drugs
dexamethasonemethylprednisolone
03
Conditions
asthma
Beyond the preview
Go deeper on IRCT20251201068170N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251201068170N1.